Press Releases

Recro Pharma Restructures Acute Care Segment While Continuing To Execute on Strong CDMO Segment Performance

Apr 03, 2019 4:05pm EDT

Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors

Mar 25, 2019 7:00am EDT

Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam

Mar 22, 2019 3:30pm EDT

Recro Pharma to Host Educational Symposium on Pain Management Options in Total Joint Replacements at the American Academy of Orthopaedic Surgeons 2019 Annual Meeting

Mar 12, 2019 7:00am EDT

Recro Pharma Obtains $40.5 Million of Non-Dilutive Capital Through Expanded Credit Facility

Mar 04, 2019 7:00am EST

Recro Pharma Announces Publication of Phase III IV Meloxicam Clinical Safety and Opioid Use Data in the Journal Clinical Pharmacology in Drug Development

Feb 25, 2019 4:05pm EST

Recro Pharma Announces New IV Meloxicam Data Publication in the Journal Regional Anesthesia & Pain Medicine

Feb 20, 2019 7:00am EST

Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018

Feb 19, 2019 7:00am EST

Recro Pharma to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call and Webcast on February 19, 2019

Feb 14, 2019 7:00am EST

Recro Pharma Announces Five-Year Manufacturing and Supply Agreement Between Novartis and Recro Gainesville

Feb 11, 2019 7:00am EST

1
2
3
4
5
6
7
8
9
10
...16